BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BRAINSTORM CELL THERAPEUTICS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026
- Market cap
- $8.50M
- P/E (TTM)
- –
- Dividend yield
- –